Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Mirum Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Price |
Fee Rate |
Amount of Registration Fee | |||||||
| Equity | 2020 Inducement Plan Common Stock, $0.0001 par value per share |
Other(2) | 1,500,000(3) | $27.25 | $40,875,000 | 0.00014760 | $6,033.15 | |||||||
| Total Offering Amounts | $40,875,000 | — | ||||||||||||
| Total Fees Previously Paid | — | |||||||||||||
| Total Fee Offsets | — | |||||||||||||
| Net Fee Due | $6,033.15 | |||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 (this “Registration Statement”) shall also cover any additional shares of common stock (“Common Stock”) of Mirum Pharmaceuticals, Inc. (the “Registrant”) that become issuable under the Registrant’s 2020 Inducement Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum aggregate offering price per share and proposed maximum aggregate offering price are calculated using the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on October 27, 2023, rounded to the nearest cent. |
| (3) | Represents shares of the Registrant’s Common Stock that were added to the 2020 Inducement Plan pursuant to share reserve increases approved by the Compensation Committee of the Registrant’s Board of Directors. |